Remove Bioinformatics Remove Life Science Remove Packaging Remove Production
article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. For the AAV packaging service, what is the titer of the viral particles? Dr O’Hara also provided an AAV plasmid preparation case study. Why are those important?

article thumbnail

Exclusive event on using adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Learn how to use adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

article thumbnail

A guide to using adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. For the AAV packaging service, what is the titer of the viral particles? Dr O’Hara also provided an AAV plasmid preparation case study.

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

As the shift to home working proliferated during the pandemic, work became decentralised – and many businesses were able to be productive with a workforce at home. data processing systems that support bioinformatics modelling) and digital record systems (e.g. You can read part one of this article here. About the interviewees.